trimetazidine has been researched along with Cardiotoxicity in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 4 (66.67) | 2.80 |
Authors | Studies |
---|---|
Bai, J; Bai, N; Chi, J; Ding, X; Liu, J; Nie, C; Yang, W; Zhan, C; Zheng, M | 1 |
Ahmed, LK; Ahmed, YH; El-Shoura, EAM; Salem, MA; Zaafar, D | 1 |
Zhao, L | 2 |
Küçük, M; Öncel, CR | 1 |
Kavtaradze, N; Saganelidze, K | 1 |
1 review(s) available for trimetazidine and Cardiotoxicity
Article | Year |
---|---|
[MODERN ASPECTS OF DIAGNOSIS AND TREATMENT OF HEART FAILURE, AS A MANIFESTATION OF ANTHRACYCLINE CARDIOTOXICITY (REVIEW)].
Topics: Anthracyclines; Antineoplastic Agents; Biomarkers; Cardiomyopathies; Cardiotonic Agents; Cardiotoxicity; Echocardiography; Elapid Venoms; Heart; Heart Failure; Humans; Ivabradine; Natriuretic Peptide, C-Type; Neoplasms; Survival Analysis; Trastuzumab; Trimetazidine; Troponin I | 2018 |
5 other study(ies) available for trimetazidine and Cardiotoxicity
Article | Year |
---|---|
Combined Usage of Trimetazidine With 3-Bromopyruvate May Lead to Cardiotoxicity by Activating Oxidative Stress and Apoptosis in Rats.
Topics: Adenosine Triphosphate; Animals; Apoptosis; Cardiotoxicity; Cardiovascular Agents; Energy Metabolism; Enzyme Inhibitors; Heart Diseases; Male; Myocytes, Cardiac; Oxidative Stress; Pyruvates; Rats, Wistar; Signal Transduction; Trimetazidine; Ventricular Function, Left | 2021 |
Combined β-sitosterol and trimetazidine mitigate potassium dichromate-induced cardiotoxicity in rats through the interplay between NF-κB/AMPK/mTOR/TLR4 and HO-1/NADPH signaling pathways.
Topics: AMP-Activated Protein Kinases; Animals; Biomarkers; Cardiotoxicity; Male; NADP; NF-kappa B; Potassium Dichromate; Rats; Saline Solution; Signal Transduction; Toll-Like Receptor 4; TOR Serine-Threonine Kinases; Trimetazidine | 2023 |
Protective effects of trimetazidine and coenzyme Q10 on cisplatin-induced cardiotoxicity by alleviating oxidative stress and mitochondrial dysfunction.
Topics: Animals; Antioxidants; Apoptosis; Cardiotoxicity; Cell Survival; Cisplatin; Drug Therapy, Combination; Mitochondria; Myocytes, Cardiac; Rats; Trimetazidine; Ubiquinone | 2019 |
The cardioprotective role of trimetazidine on cisplatin-induced cardiotoxicity.
Topics: Cardiotoxicity; Cisplatin; Humans; Mitochondria; Oxidative Stress; Trimetazidine; Ubiquinone | 2020 |
Author`s Reply.
Topics: Cardiotoxicity; Cisplatin; Humans; Trimetazidine | 2020 |